Medicated Skin Care in Mexico
Diabetes rates are soaring in Mexico due to unhealthy diets and obesity, reaching more than nine million people in 2011 according to the Mexican Diabetes Federation. Due to the wide range of side effects caused by diabetes, the epidemic is impacting many categories in the field of health. One of these side effects is the appearance of skin fungus, driving demand for antifungal products. Some companies, such as local player Genomma Lab, are capitalising on this epidemic, launching several new...
Euromonitor International's Medicated Skin Care in Mexico report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International's Medicated Skin Care in Mexico report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Medicated Skin Care market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
Table 3 Medicated Skin Care Company Shares by Value 2007-2011
Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
Table 5 Hair Loss Treatments Brand Shares by Value 2008-2011
Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Bayer De México SA De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 1 Bayer de México: Key Facts
Summary 2 Bayer de México: Operational Indicators
Company Background
Production
Summary 3 Bayer de México SA de CV: Production Statistics 2011
Competitive Positioning
Summary 4 Bayer de México SA de CV: Competitive Position 2011
Boehringer Ingelheim Promeco SA De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 5 Boehringer Ingelheim Promeco SA de CV: Key Facts
Summary 6 Boehringer Ingelheim Promeco SA de CV: Operational Indicators
Company Background
Production
Summary 7 Boehringer Ingelheim Promeco SA de CV: Production Statistics 2011
Competitive Positioning
Summary 8 Boehringer Ingelheim Promeco SA de CV: Competitive Position 2011
Farmacias Similares SA De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 9 Farmacias Similares SA de CV: Key Facts
Summary 10 Farmacias Similares SA de CV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 11 Farmacias Similares SA de CV: Competitive Position 2011
Genomma Lab Internacional Sab De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 12 Genomma Lab Internacional SAB de CV: Key Facts
Summary 13 Genomma Lab Internacional SAB de CV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 14 Genomma Lab Internacional SAB de CV: Competitive Position 2011
GlaxoSmithKline México SA De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 15 GlaxoSmithKline México SA de CV: Key Facts
Summary 16 GlaxoSmithKline México SA de CV: Operational Indicators
Company Background
Production
Summary 17 GlaxoSmithKline México SA de CV: Production Statistics 2010
Competitive Positioning
Summary 18 GlaxoSmithKline México SA de CV: Competitive Position 2011
Merck-méxico SA in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 19 Merck-México SA: Key Facts
Summary 20 Merck-México SA: Operational Indicators
Company Background
Production
Summary 21 Merck-México SA: Production Statistics 2011
Competitive Positioning
Summary 22 Merck-México SA: Competitive Position 2011
Pfizer SA De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 23 Pfizer SA de CV: Key Facts
Summary 24 Pfizer SA de CV: Operational Indicators
Company Background
Production
Summary 25 Pfizer SA de CV: Production Statistics 2011
Competitive Positioning
Summary 26 Pfizer SA de CV: Competitive Position 2011
Executive Summary
Consumer Health Achieves Highest Growth Since 2006
Weight Management Grows Substantially
Herbalife Takes Major Step Forward in 2011
Inexpensive Medical Consultation Offices Attract Clients
Government Cracks Down on 'miracle' Products
Key Trends and Developments
Genomma Lab Internacional Sab De Cv Innovates With Flexible and Fast Business Model, Grows Significantly
Antibiotics Law Reinforce Reshapes the Sales of Medicines in the Country
New Demographic Landscape Shapes Health Legislation
Possible New Regulations To Favour International Products
National Health Program Very Active During Calderon Administration
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 9 Life Expectancy at Birth 2006-2011
Market Data
Table 10 Sales of Consumer Health by Category: Value 2006-2011
Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 12 Consumer Health Company Shares 2007-2011
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements' Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 27 OTC Switches 2009-2011
Definitions
Sources
Summary 28 Research Sources
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
Table 3 Medicated Skin Care Company Shares by Value 2007-2011
Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
Table 5 Hair Loss Treatments Brand Shares by Value 2008-2011
Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Bayer De México SA De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 1 Bayer de México: Key Facts
Summary 2 Bayer de México: Operational Indicators
Company Background
Production
Summary 3 Bayer de México SA de CV: Production Statistics 2011
Competitive Positioning
Summary 4 Bayer de México SA de CV: Competitive Position 2011
Boehringer Ingelheim Promeco SA De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 5 Boehringer Ingelheim Promeco SA de CV: Key Facts
Summary 6 Boehringer Ingelheim Promeco SA de CV: Operational Indicators
Company Background
Production
Summary 7 Boehringer Ingelheim Promeco SA de CV: Production Statistics 2011
Competitive Positioning
Summary 8 Boehringer Ingelheim Promeco SA de CV: Competitive Position 2011
Farmacias Similares SA De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 9 Farmacias Similares SA de CV: Key Facts
Summary 10 Farmacias Similares SA de CV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 11 Farmacias Similares SA de CV: Competitive Position 2011
Genomma Lab Internacional Sab De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 12 Genomma Lab Internacional SAB de CV: Key Facts
Summary 13 Genomma Lab Internacional SAB de CV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 14 Genomma Lab Internacional SAB de CV: Competitive Position 2011
GlaxoSmithKline México SA De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 15 GlaxoSmithKline México SA de CV: Key Facts
Summary 16 GlaxoSmithKline México SA de CV: Operational Indicators
Company Background
Production
Summary 17 GlaxoSmithKline México SA de CV: Production Statistics 2010
Competitive Positioning
Summary 18 GlaxoSmithKline México SA de CV: Competitive Position 2011
Merck-méxico SA in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 19 Merck-México SA: Key Facts
Summary 20 Merck-México SA: Operational Indicators
Company Background
Production
Summary 21 Merck-México SA: Production Statistics 2011
Competitive Positioning
Summary 22 Merck-México SA: Competitive Position 2011
Pfizer SA De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 23 Pfizer SA de CV: Key Facts
Summary 24 Pfizer SA de CV: Operational Indicators
Company Background
Production
Summary 25 Pfizer SA de CV: Production Statistics 2011
Competitive Positioning
Summary 26 Pfizer SA de CV: Competitive Position 2011
Executive Summary
Consumer Health Achieves Highest Growth Since 2006
Weight Management Grows Substantially
Herbalife Takes Major Step Forward in 2011
Inexpensive Medical Consultation Offices Attract Clients
Government Cracks Down on 'miracle' Products
Key Trends and Developments
Genomma Lab Internacional Sab De Cv Innovates With Flexible and Fast Business Model, Grows Significantly
Antibiotics Law Reinforce Reshapes the Sales of Medicines in the Country
New Demographic Landscape Shapes Health Legislation
Possible New Regulations To Favour International Products
National Health Program Very Active During Calderon Administration
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 9 Life Expectancy at Birth 2006-2011
Market Data
Table 10 Sales of Consumer Health by Category: Value 2006-2011
Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 12 Consumer Health Company Shares 2007-2011
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements' Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 27 OTC Switches 2009-2011
Definitions
Sources
Summary 28 Research Sources
